<DOC>
	<DOC>NCT02278367</DOC>
	<brief_summary>This study is designed to expand the database of 18F-AV-1451 safety and tau binding as measured by PET imaging and to provide standardized conditions for 18F-AV-1451 use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.</brief_summary>
	<brief_title>Clinical Evaluation of 18F-AV-1451</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Subjects should meet inclusion and exclusion criteria for the companion protocol in addition to the criteria below. Subjects who have a historical volumetric MRI as part of the companion study Have clinically significant cardiac, hepatic, renal, pulmonary, metabolic, or endocrine disturbances Have a screening ECG with QTc &gt; 450 msec if male or QTc &gt; 470 msec if female Have a history of additional risk factors for Torsades de Pointes (TdP) or are taking drugs known to cause QTprolongation. Patients with a prolonged QTc interval in the setting of intraventricular conduction block may be enrolled with sponsor approval Have a history of drug or alcohol dependence within the last year, or prior prolonged history of dependence unless approved by the sponsor Are females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception Have a history of relevant severe drug allergy or hypersensitivity Are patients who have received an investigational medication under an FDA IND protocol within 30 days prior to the planned imaging session for this study Are patients with current clinically significant unstable medical comorbidities Are patients who have received a radiopharmaceutical for imaging or therapy within the past 24 hours prior to the imaging session for this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>